drugs

Major Drug Retailers Lose Over USD 12.8 Billion in Value

Major Drug Retailers Lose Over USD 12.8 Billion in Value

Shares of CVS (NYSE: CVS), Walgreens (NYSE: WBA) and Rite-Aid (NYSE: RAD) lost USD 12.8 Billion in value after Amazon.com, Inc. (NASDAQ: AMZN) announced that it had signed an agreement to buy the online pharmacy, PillPack, on Thursday.PillPack organ..

Walgreens has joined as the newest member of Dow with the exit of General Electric on Tuesday.

Walgreens has joined as the newest member of Dow with the exit of General Electric on Tuesday.

Walgreens Boots Alliance Inc (NASDAQ: WBA) is a giant drug store chain that started in Chicago in 1901, and chances are you've either heard of the brand or shopped at one. The latter part of the company name, Boots Alliance, refers to the c..

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Inc. (NYSE: ABBV) reported its fourth quarter financial results for fiscal year 2017. The pharmaceutical company reported better than expected earnings sending shares 13.5 percent before market close on Friday.For the fourth quarter, AbbVie r..

Biogen Misses Earnings but Tops Revenue Estimates

Biogen Misses Earnings but Tops Revenue Estimates

Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter financial results for fiscal year 2017. The U.S. drug-maker fell short on earnings estimates, but topped revenue estimates, sending shares 3 percent higher during Thursday’s pre-marke..

Teva Pharmaceuticals to Cut 25% of Jobs

Teva Pharmaceuticals to Cut 25% of Jobs

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), based in Israel, is one of the world’s largest makers of generic drugs. The pharmaceutical giant has had a rough year, facing declining prices for generic drugs and the loss of a major branded d..

Teva May Cut 10,000 Jobs

Teva May Cut 10,000 Jobs

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has announced the cut of 10,000 jobs as the company aims to reduce $1.5 billion to $2 billion in costs over the next two years. Following this announcement, the drug maker’s U.S. shares increase..

Spectrum shares surge on positive results from lung cancer treatment trial

Spectrum shares surge on positive results from lung cancer treatment trial

Spectrum Pharmaceutical Inc. (NASDAQ: SPPI) shares surged over 40 percent on Tuesday at open after its announcement of positive results from its Phase 2 clinical study of poziotinib. The announcement was presented at the 18th IASLC World Conference ..